Key statistics
On Monday, VIVA Biotech Holdings (1873:HKG) closed at 2.30, -29.66% below its 52-week high of 3.27, set on Oct 08, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.31 |
|---|---|
| High | 2.35 |
| Low | 2.26 |
| Bid | 2.30 |
| Offer | 2.32 |
| Previous close | 2.31 |
| Average volume | 6.72m |
|---|---|
| Shares outstanding | 2.13bn |
| Free float | 1.21bn |
| P/E (TTM) | 32.48 |
| Market cap | 4.90bn HKD |
| EPS (TTM) | 0.0708 HKD |
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
- Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
- Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
- Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
- Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
